E

Eloxx Pharmaceuticals Inc
D

ELOX

20.700
USD
2.35
(12.78%)
مغلق
حجم التداول
1,931
الربح لكل سهم
-8
العائد الربحي
-
P/E
6
حجم السوق
71,131,700
المقالات
المزيد

العنوان: Eloxx Pharmaceuticals Inc

القطاع: الرعاية الصحية
الصناعة: Biotechnology
Eloxx Pharmaceuticals Inc is a clinical-stage biopharmaceutical company engaged in developing novel, small-molecule product candidates designed to modulate the ribosome and promote readthrough of premature stop codons induced by nonsense mutations (NMs) to enable the production of full-length proteins. The exaluren, the company's investigational drug product for the treatment of rare kidney diseases, and, through the collaboration with Almirall, S.A. (Almirall), ZKN-013 for the treatment of rare skin diseases.